Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
31.3M
-
Shares change
-
+2.88M
-
Total reported value, excl. options
-
$953M
-
Value change
-
+$95.7M
-
Put/Call ratio
-
0.91
-
Number of buys
-
78
-
Number of sells
-
-46
-
Price
-
$30.47
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2015
153 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q4 2015.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.3M shares
of 101M outstanding shares and own 30.98% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.59M shares), ADAGE CAPITAL PARTNERS GP LLC (2.06M shares), Visium Asset Management, LP (2.03M shares), WADDELL & REED FINANCIAL INC (2.03M shares), BlackRock Fund Advisors (1.9M shares), JPMORGAN CHASE & CO (1.75M shares), JANUS CAPITAL MANAGEMENT LLC (1.73M shares), BlackRock Institutional Trust Company, N.A. (1.24M shares), EcoR1 Capital, LLC (1.22M shares), and STATE STREET CORP (1.16M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.